Quipt Home Medical (QIPT) acknowledges receipt of a notice from Philotimo Fund, an entity affiliated with Kanen Wealth Management, and David Kanen, purporting to provide notice of its intent to solicit proxies in support of four director candidates to the company’s Board of Directors in opposition to the company’s four director candidates to the Board. The company said, “The company remains steadfast in its mission to deliver long-term value to all shareholders. As part of the company’s ongoing commitment to corporate governance, the Board and the Nominating and Corporate Governance Committee of the Board will thoroughly review and evaluate KWM’s notice and any additional requests for compliance with its established procedures under the company’s Articles and all applicable laws.” At this time, the company has not received a timely, valid and compliant notice for nominating any directors to our Board pursuant to both U.S. securities laws and the company’s Articles.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QIPT:
- Quipt Home Medical To Release Q1 2025 Financial Results
- Quipt Home Medical price target lowered to C$7 from C$7.50 at Stifel
- Quipt Home Medical price target lowered to $6 from $7 at Benchmark
- Quipt Home Medical Shows Strong 2024 Financial Growth
- Quipt Home Medical reports Q4 revenue $61.3M vs $59.6M last year